Pancreatic cancer is a formidable disease and represents a major public health problem.
Globally, around 496,000 cases of pancreatic cancer are diagnosed each year, with almost …

Pancreatic cancer belongs to the most aggressive and lethal diseases. The prognosis for
this cancer is weak, and the 5-year survival rate is less than 7%. The most common …

The microbiota impact on human diseases is well-known, and a growing body of literature is
providing evidence about the complex interplay between microbiota-immune system-human …

The intestinal microbiota has an increasingly recognized role in the development of cancer,
in which microbial interactions play a more important than expected role. Pancreatic cancer …

Simple Summary Pancreatic cancer (PC) continues to be characterized by high morbidity
and mortality, owing to the fact, among others, that it is often diagnosed at late stages. Thus …

Microbiota is just beginning to be recognized as an important player in carcinogenesis and
the interplay among microbes is greater than expected. Pancreatic ductal adenocarcinoma …

Many risk factors for pancreatic cancer are related with microbiome alteration. In the past few
years, the human microbiome and its relation with the immune system have been linked with …

Simple Summary Pancreatic cancer is still burdened with a severe prognosis, despite
advances in the diagnosis and surgical management of this disease. The gut microbiome is …

Simple Summary Pancreatic cancer is a devasting disease that has unfortunately proven
very difficult to treat. Exploring new therapeutic options and getting an early diagnosis is …

Simple Summary The microorganisms colonizing the epithelial surfaces of the human body,
called microbiota, have been shown to influence the initiation, progression and response to …